Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 31Terminated 6Active not recruiting 5Withdrawn 1Recruiting 1

Sponsor Class

OTHER 37OTHER_GOV 3INDUSTRY 3NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 116Magnetic Resonance Spectroscopy 77Biopsy 71Cyclophosphamide 24pembrolizumab 22Cisplatin 21fludarabine 18Platinum 171,2-diaminocyclohexaneplatinum II citrate 17Taxes 16Paclitaxel 16Carboplatin 16Nivolumab 15Immunoglobulin G 15Disulfides 15X-Rays 13Radiation 13venetoclax 12Doxorubicin 12Radiotherapy 11Gemcitabine 11durvalumab 10Prednisone 9cabozantinib 8aldesleukin 8olaparib 7decitabine and cedazuridine drug combination 7atezolizumab 7Cytarabine 7lutetium Lu 177 dotatate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × NIH × Granulocyte Colony-Stimulating Factor × Clear all
NCT07012044 2026-05-27

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1 Recruiting
47 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡